Felga GE - Search Results

1

Response to transarterial chemoembolization in candidates with hepatocellular carcinoma within Milan criteria does not predict post-transplant disease-free survival.

Salvalaggio PR, Felga GE, Alves JA, Meirelles RF Jr, Almeida MD, de Rezende MB. Salvalaggio PR, et al. Among authors: felga ge. Transplant Proc. 2014 Jul-Aug;46(6):1799-802. doi: 10.1016/j.transproceed.2014.05.039. Transplant Proc. 2014. PMID: 25131040

2

Results of retransplantation for primary nonfunction in a single center.

Coelho MP, Afonso RC, Hidalgo R, Felga G, Almeida MD, Della-Guardia B, Rezende MB, Meira-Filho SP, Ferraz-Neto BH. Coelho MP, et al. Transplant Proc. 2011 Jan-Feb;43(1):174-6. doi: 10.1016/j.transproceed.2010.12.003. Transplant Proc. 2011. PMID: 21335180

3

Clinical profile and liver explant findings in patients with and without pretransplant downstaging for hepatocellular carcinoma.

Felga G, Evangelista AS, Salvalaggio PR, Curvelo LA, Della Guardia B, Almeida MD, Afonso RC, Ferraz-Neto BH. Felga G, et al. Transplant Proc. 2012 Oct;44(8):2399-402. doi: 10.1016/j.transproceed.2012.07.135. Transplant Proc. 2012. PMID: 23026605

4

Early allograft dysfunction and liver transplant outcomes: a single center retrospective study.

Salvalaggio PR, Felga GE, Afonso RC, Ferraz-Neto BH. Salvalaggio PR, et al. Among authors: felga ge. Transplant Proc. 2012 Oct;44(8):2449-51. doi: 10.1016/j.transproceed.2012.08.002. Transplant Proc. 2012. PMID: 23026617

5

Hepatocellular carcinoma recurrence among liver transplant recipients within the Milan criteria.

Felga G, Evangelista AS, Salvalaggio PR, Curvelo LA, Della Guardia B, Almeida MD, Afonso RC, Ferraz-Neto BH. Felga G, et al. Transplant Proc. 2012 Oct;44(8):2459-61. doi: 10.1016/j.transproceed.2012.07.004. Transplant Proc. 2012. PMID: 23026620

6

A proposal to grade the severity of early allograft dysfunction after liver transplantation.

Salvalaggio P, Afonso RC, Felga G, Ferraz-Neto BH. Salvalaggio P, et al. Einstein (Sao Paulo). 2013 Jan-Mar;11(1):23-31. doi: 10.1590/s1679-45082013000100006. Einstein (Sao Paulo). 2013. PMID: 23579740 Free PMC article.

7

Time is a crucial factor for the use of oncological treatment for post-transplantation recurrence of hepatocellular carcinoma.

Felga G, Salvalaggio PR, de Rezende MB, de Almeida MD. Felga G, et al. J Hepatol. 2014 Jan;60(1):229-30. doi: 10.1016/j.jhep.2013.08.026. Epub 2013 Sep 7. J Hepatol. 2014. PMID: 24021423 Free article. No abstract available.

8

Liver transplantation in Latin America: the state-of-the-art and future trends.

Salvalaggio PR, Caicedo JC, de Albuquerque LC, Contreras A, Garcia VD, Felga GE, Maurette RJ, Medina-Pestana JO, Niño-Murcia A, Pacheco-Moreira LF, Rocca J, Rodriguez-Davalos M, Ruf A, Rusca LA, Vilatoba M. Salvalaggio PR, et al. Among authors: felga ge. Transplantation. 2014 Aug 15;98(3):241-6. doi: 10.1097/TP.0000000000000198. Transplantation. 2014. PMID: 25093292

9

Liver transplantation for unresectable hepatocellular carcinoma in elderly patients: what to expect.

Felga G, Silva Evangelista A, Rogério de Oliveira Salvalaggio P, Bruno de Rezende M, Dias de Almeida M. Felga G, et al. Transplant Proc. 2014 Jul-Aug;46(6):1764-7. doi: 10.1016/j.transproceed.2014.05.004. Transplant Proc. 2014. PMID: 25131031

10

List and liver transplant survival according to waiting time in patients with hepatocellular carcinoma.

Salvalaggio PR, Felga G, Axelrod DA, Della Guardia B, Almeida MD, Rezende MB. Salvalaggio PR, et al. Am J Transplant. 2015 Mar;15(3):668-77. doi: 10.1111/ajt.13011. Epub 2015 Feb 3. Am J Transplant. 2015. PMID: 25650130 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

32 results

Search Page

Filters